Literature DB >> 7448208

Effect of thioacetamide, growth hormone or partial hepatectomy on spermidine acetylase activity of rat liver cytosol.

I Matsui, A E Pegg.   

Abstract

Rat liver cytosol extracts catalyzed the formation of monoacetylspermidine when incubated with acetyl-CoA and spermidine. This activity was enhanced 15-fold by administration of thioacetamide (150 mg/kg). The peak of activity occurred 18-24 h after treatment with the drug and then declined reaching control levels by 76 h. Previous studies have shown that ornithine decarboxylase activity was also greatly increased over this time period. Putrescine content in the liver was increased 80-90-fold at 18-24 h and then declined. Spermidine levels were decreased significantly over the period 12-24 h after thioacetamide treatment and then increased substantially at later times. These results are consistent with the hypothesis that, at early times after administration of thioacetamide, the increase in putrescine content is brought about both by decarboxylation of ornithine and by degradation of monoacetylspermidine. Spermidine acetylase activity was also measured in liver extracts prepared after two other physiological stimuli known to enhance ornithine decarboxylase activity were used. Both growth hormone treatment and partial hepatectomy produced an early 2-3-fold increase in the cytosolic spermidine acetylase activity.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7448208     DOI: 10.1016/0304-4165(80)90040-9

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  13 in total

1.  Insulin and glucagon therapy of acute hepatic failure.

Authors:  K Fujiwara; I Ogata; Y Sato; T Tomiya; Y Ohta; Y Oka; S Nagoshi; S Yamada; N Masaki; K Takatsuki
Journal:  Dig Dis Sci       Date:  1991-06       Impact factor: 3.199

2.  Accumulation of N1-acetylspermidine in heart and spleen of isoprenaline-treated rats.

Authors:  C Stefanelli; D Carati; C Rossoni; F Flamigni; C M Caldarera
Journal:  Biochem J       Date:  1986-08-01       Impact factor: 3.857

3.  Polyamine acetylations in normal and neoplastic growth processes.

Authors:  M A Desiderio; L Bardella
Journal:  Amino Acids       Date:  1995-03       Impact factor: 3.520

4.  Structure-activity relations of S-adenosylmethionine decarboxylase inhibitors on the growth of MCF-7 breast cancer cells.

Authors:  T Thomas; C A Faaland; S Adhikarakunnathu; T J Thomas
Journal:  Breast Cancer Res Treat       Date:  1996       Impact factor: 4.872

Review 5.  Overview of the brain polyamine-stress-response: regulation, development, and modulation by lithium and role in cell survival.

Authors:  Gad M Gilad; Varda H Gilad
Journal:  Cell Mol Neurobiol       Date:  2003-10       Impact factor: 5.046

6.  Antiproliferative and apoptotic effects in rat and human hepatoma cell cultures of the orally active iron chelator ICL670 compared to CP20: a possible relationship with polyamine metabolism.

Authors:  G Lescoat; K Chantrel-Groussard; N Pasdeloup; H Nick; P Brissot; F Gaboriau
Journal:  Cell Prolif       Date:  2007-10       Impact factor: 6.831

7.  Studies of the specificity and kinetics of rat liver spermidine/spermine N1-acetyltransferase.

Authors:  F Della Ragione; A E Pegg
Journal:  Biochem J       Date:  1983-09-01       Impact factor: 3.857

8.  Studies of the acetyl-CoA-binding site of rat liver spermidine/spermine N1-acetyltransferase.

Authors:  F Della Ragione; B G Erwin; A E Pegg
Journal:  Biochem J       Date:  1983-09-01       Impact factor: 3.857

9.  Induction of spermidine/spermine N1-acetyltransferase activity in Chinese-hamster ovary cells by N1N11-bis(ethyl)norspermine (corrected) and related compounds.

Authors:  A E Pegg; R Pakala; R J Bergeron
Journal:  Biochem J       Date:  1990-04-15       Impact factor: 3.857

10.  Elevation of N1-acetylspermidine and putrescine in hepatic tissues of patients with fulminant hepatitis and liver cirrhosis.

Authors:  H Sugimoto; S Sakurai; T Abe; H Takagi; H Takahashi; J Takezawa; T Nagamine; S Matsuzaki
Journal:  J Gastroenterol       Date:  1994-04       Impact factor: 7.527

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.